Advertisement
Canada markets close in 5 hours 18 minutes
  • S&P/TSX

    22,172.18
    +65.10 (+0.29%)
     
  • S&P 500

    5,251.75
    +3.26 (+0.06%)
     
  • DOW

    39,739.99
    -20.09 (-0.05%)
     
  • CAD/USD

    0.7379
    +0.0007 (+0.09%)
     
  • CRUDE OIL

    82.36
    +1.01 (+1.24%)
     
  • Bitcoin CAD

    96,800.45
    +1,641.32 (+1.72%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,228.10
    +15.40 (+0.70%)
     
  • RUSSELL 2000

    2,121.36
    +7.01 (+0.33%)
     
  • 10-Yr Bond

    4.2020
    +0.0060 (+0.14%)
     
  • NASDAQ

    16,396.80
    -2.72 (-0.02%)
     
  • VOLATILITY

    13.04
    +0.26 (+2.03%)
     
  • FTSE

    7,960.33
    +28.35 (+0.36%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6823
    +0.0018 (+0.26%)
     

Why Macy's (M) Stock is Rallying Today

Shares of department store giant Macy’s M saw a nice gain on Thursday, closing up 5.5%.

The company reported preliminary first quarter results. It expects to report an operating loss between $905 million and $1.1 billion andnet sales in the range of $3 billion and $3.03 billion. Analysts are forecasting a loss of 98 cents per share and sales of $3.6 billion.

All of Macy’s stores, including Bloomingdale’s and Bluemercury, temporarily shuttered on March 18. The company is currently working on reopening its stores. 190 Macy’s and Bloomingdale’s stores are now fully operational, and 80 more will be open for Memorial Day weekend.

CEO Jeff Gennette said that its digital business saw a “steady uptick” in April, and customer demand over the past two weeks has been “moderately higher than we anticipated.” He also noted that Macy’s performance in February was solid before the pandemic hit.

ADVERTISEMENT

Macy’s will release its full Q1 results on July 1.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Macys, Inc. (M) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research